How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake

Obesity

Volumn 24, Issue 11, 2016, Pages 2289-2295

  Polidori, David ^a   Sanghvi, Arjun ^b   Seeley, Randy J ^c   Hall, Kevin D ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANAGLIFLOZIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE; SLC5A2 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 2;

ADULT; APPETITE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DRUG EFFECT; ENERGY EXPENDITURE; FEEDBACK SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; QUANTITATIVE ANALYSIS; TREATMENT DURATION; URINARY EXCRETION; URINARY GLUCOSE EXCRETION; WEIGHT REDUCTION; AGED; ANTAGONISTS AND INHIBITORS; BODY MASS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGICAL FEEDBACK; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; THEORETICAL MODEL; WAIST CIRCUMFERENCE;

ADULT; AGED; APPETITE; BIOMARKERS; BODY MASS INDEX; BODY WEIGHT; CANAGLIFLOZIN; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; ENERGY METABOLISM; FEEDBACK, PHYSIOLOGICAL; FEMALE; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; SODIUM-GLUCOSE TRANSPORTER 2; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84993982735     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21653     Document Type: Article

References (40)

1. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-628.
2. Berthoud HR. The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc 2012;71:478-487.
3. Gibbons C, Finlayson G, Dalton M, Caudwell P, Blundell JE. Metabolic phenotyping guidelines: studying eating behaviour in humans. J Endocrinol 2014;222:G1-G12.
4. Edholm OG, Adam JM, Healy MJ, Wolff HS, Goldsmith R, Best TW. Food intake and energy expenditure of army recruits. Br J Nutr 1970;24:1091-1107.
5. Schoeller DA. How accurate is self-reported dietary energy intake? Nutr Rev 1990;48:373-379.
6. Sanghvi A, Redman LA, Martin CK, Ravussin E, Hall KD. Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. Am J Clin Nutr 2015;102:353-358.
7. Blundell JE, Gibbons C, Caudwell P, Finlayson G, Hopkins M. Appetite control and energy balance: impact of exercise. Obes Rev 2015;16(Suppl 1):67-76.
8. Stenlof K, Cefalu WT, Kim KA, et al. Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. Curr Med Res Opin 2014;30:163-175.
9. Devineni D, Polidori D. Clinical pharmacokinetic, pharmacodynamic, and drug-drug interaction profile of canagliflozin, a sodium-glucose co-transporter 2 inhibitor. Clin Pharmacokinet 2015;54:1027-1041.
10. Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 2014;124:499-508.
11. Liang Y, Arakawa K, Ueta K, et al. Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models. PLoS One 2012;7:e30555.
12. Hall KD, Guo J, Dore M, Chow CC. The progressive increase of food waste in America and its environmental impact. PLoS One 2009;4:e7940.
13. Hall KD, Jordan PN. Modeling weight-loss maintenance to help prevent body weight regain. Am J Clin Nutr 2008;88:1495-1503.
14. Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011;378:826-837.
15. Broyles ST, Bouchard C, Bray GA, et al. Consistency of fat mass–fat-free mass relationship across ethnicity and sex groups. Br J Nutr 2011;105:1272-1276.
16. Brady I, Hall KD. Dispatch from the field: is mathematical modeling applicable to obesity treatment in the real world? Obesity (Silver Spring) 2014;22:1939-1941.
17. Tam J, Fukumura D, Jain RK. A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight. Cell Metab 2009;9:52-63.
18. Ferrannini G, Hach T, Crowe S, Sanghvi A, Hall KD, Ferrannini E. Energy balance after sodium glucose cotransporter 2 (SGLT2) inhibition. Diabetes Care 2015;38:1730-1735.
19. Heshka S, Anderson JW, Atkinson RL, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003;289:1792-1798.
20. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007;107:1755-1767.
21. Ravussin E, Redman LM, Rochon J, et al. A two-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol 2015;70:1097-1104.
22. Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol 2011;301:R581-R600.
23. Keys A. The Biology of Human Starvation. Minneapolis: University of Minnesota Press; 1950.
24. Heyman MB, Young VR, Fuss P, Tsay R, Joseph L, Roberts SB. Underfeeding and body weight regulation in normal-weight young men. Am J Physiol 1992;263:R250-R257.
25. Roberts SB, Fuss P, Heyman MB, et al. Control of food intake in older men. JAMA 1994;272:1601-1606.
26. Winkels RM, Jolink-Stoppelenburg A, de Graaf K, Siebelink E, Mars M, de Groot L. Energy intake compensation after 3 weeks of restricted energy intake in young and elderly men. J Am Med Dir Assoc 2011;12:277-286.
27. Blundell JE, Finlayson G, Gibbons C, Caudwell P, Hopkins M. The biology of appetite control: do resting metabolic rate and fat-free mass drive energy intake? Physiol Behav 2015;152:473-478.
28. Dulloo AG, Jacquet J, Girardier L. Poststarvation hyperphagia and body fat overshooting in humans: a role for feedback signals from lean and fat tissues. Am J Clin Nutr 1997;65:717-723.
29. Almiron-Roig E, Palla L, Guest K, et al. Factors that determine energy compensation: a systematic review of preload studies. Nutr Rev 2013;71:458-473.
30. Bellisle F, Perez C. Low-energy substitutes for sugars and fats in the human diet: impact on nutritional regulation. Neurosci Biobehav Rev 1994;18:197-205.
31. Stubbs RJ, Harbron CG, Murgatroyd PR, Prentice AM. Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr 1995;62:316-329.
32. Stubbs RJ, Ritz P, Coward WA, Prentice AM. Covert manipulation of the ratio of dietary fat to carbohydrate and energy density: effect on food intake and energy balance in free-living men eating ad libitum. Am J Clin Nutr 1995;62:330-337.
33. Lovejoy JC, Smith SR, Bray GA, et al. A paradigm of experimentally induced mild hyperthyroidism: effects on nitrogen balance, body composition, and energy expenditure in healthy young men. J Clin Endocrinol Metab 1997;82:765-770.
34. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365:1597-1604.
35. Speakman JR, Levitsky DA, Allison DB, et al. Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity. Dis Models Mech 2011;4:733-745.
36. Greenberg I, Stampfer MJ, Schwarzfuchs D, Shai I. Adherence and success in long-term weight loss diets: the dietary intervention randomized controlled trial (DIRECT). J Am Coll Nutr 2009;28:159-168.
37. Devineni D, Curtin CR, Polidori D, et al. Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus. J Clin Pharmacol 2013;53:601-610.
38. Sha S, Polidori D, Heise T, et al. Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus. Diabetes Obes Metab 2014;16:1087-1095.
39. Polidori D, Mari A, Ferrannini E. Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes. Diabetologia 2014;57:891-901.
40. Fothergill E, Guo J, Howard L, et al. Persistent metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity (Silver Spring) 2016;24:1612-1619.